Info: Read More
  • 中药标准品生产商,产品定制服务
  • DL-高磺基丙氨酸

    DL-Homocysteic acid

    DL-高磺基丙氨酸
    产品编号 CFN90077
    CAS编号 504-33-6
    分子式 = 分子量 C4H9NO5S = 183.18
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Alkaloids
    植物来源
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    DL-高磺基丙氨酸 CFN90077 504-33-6 10mg QQ客服:1457312923
    DL-高磺基丙氨酸 CFN90077 504-33-6 20mg QQ客服:1457312923
    DL-高磺基丙氨酸 CFN90077 504-33-6 50mg QQ客服:1457312923
    DL-高磺基丙氨酸 CFN90077 504-33-6 100mg QQ客服:1457312923
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • Sapienza University of Rome (Italy)
  • Biotech R&D Institute (USA)
  • Universidad de La Salle (Mexico)
  • Lund University (Sweden)
  • Universidad de Ciencias y Artes de Chiapas (Mexico)
  • Aarhus University (Denmark)
  • Utrecht University (Netherlands)
  • Universidade Federal de Pernambuco (UFPE) (Brazil)
  • Helmholtz Zentrum München (Germany)
  • University of Virginia (USA)
  • University of Amsterdam (Netherlands)
  • Istanbul University (Turkey)
  • University of Pretoria (South Africa)
  • University of Bordeaux (France)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • J Mass Spectrom.2022, 57(2):e4810.
  • Preprints2017, 2017120176
  • Toxins (Basel).2019, 11(10):E575
  • Cancers (Basel).2023, 15(1):37.
  • Biochem Biophys Res Commun.2018, 505(1):194-200
  • Int J Cosmet Sci.2023, 45(2):155-165.
  • ACS Omega2020, 5,33,20825-20830
  • PLoS One.2022, 17(4):e0267007.
  • Nat Prod Sci.2019, 25(3):238
  • Fermentation2023, 9(10), 889
  • J Nat Med.2017, 71(2):457-462
  • Sci Rep.2017, 7:467-479
  • Analytical methods2019, 11(6)
  • BMC Complement Med Ther. 2020, 20(1):91.
  • Korean Journal of Pharmacognosy2018, 49(3):270-277
  • Mol Med Rep.2015, 12(5):7789-95
  • Pharm Biol.2017, 55(1):360-366
  • J of Physics Conference Series2019, 1349(1)
  • Evid Based Complement Alternat Med.2018, 2018:4259603
  • Phytother Res.2019, 33(4):1104-1113
  • Pharm Biol.2016, 54(7):1255-62
  • J Biotechnol.2020, 318:10-19.
  • Food Science and Human Wellness2022, 11(4):965-974
  • ...
  • 生物活性
    Description: DL-Homocysteic acid application disrupts calcium homeostasis and induces degeneration of spinal motor neurons in vivo.
    Targets: Calcium Channel
    In vitro:
    J Colloid Interface Sci. 2005 Mar 1;283(1):231-7.
    Effect of dl-homocysteic acid on W/O microemulsions of potassium naphthenate/1-octanol-n-heptane.[Pubmed: 15694443]
    The effect of DL-homocysteic acid (DL-2-amino-4-sulfonobutyric acid) on W/O microemulsion of potassium naphthenate (80%) and naphthenic acid (20%) in mixed solvent (1-octanol and n-heptane) has been found in four phases: (1) Interaction between the amino acid molecules and the polar head groups of the surfactant through hydrogen bonding enhances solubilization in the aqueous cores. (2) The interaction results in the growth of the microemulsion droplets and the homogenization of the particle size distribution. (3) The microstructure of the solubilized water remains unchanged, except that the polarity of the interface is affected. (4) The transition point is reduced to lower water content. A possible mechanism is proposed.
    In vivo:
    Am J Physiol. 1989 Mar;256(3 Pt 2):H688-96.
    Cardiorespiratory effects of DL-homocysteic acid in caudal ventrolateral medulla.[Pubmed: 2646953]

    METHODS AND RESULTS:
    We carried out experiments in urethan-anesthetized rats to determine 1) whether increasing the activity of small groups of neurons in the caudal ventrolateral medulla (CVLM) by injecting picomoles of an excitatory amino acid altered cardiovascular and/or respiratory homeostasis and 2) whether the depressor responses after chemical excitation in the CVLM were elicited only from the immunohistochemically identified catecholamine-containing cell group. In discrete sites in the CVLM, unilateral injections of 1-12 nl (20-240 pmol) of DL-homocysteic acid (DLH; 20 mM, pH 7.4) selectively or concomitantly inhibited arterial pressure, heart rate, and diaphragm electromyogram (EMG) activity. In the region in which chemical excitation slowed breathing, units were recorded extracellularly that discharged with respiratory periodicity. Sites where the smallest volumes of DLH decreased arterial pressure were located outside the immunohistochemically identified DBH-positive cell bodies.
    CONCLUSIONS:
    These data suggest that either the same or neighboring neurons in the CVLM are involved in the central neural circuitry for both cardiovascular and respiratory control and that cells other than the catecholaminergic cell group are important in medullary depressor responses.
    Acta Neuropathol. 2002 May;103(5):428-36.
    DL-Homocysteic acid application disrupts calcium homeostasis and induces degeneration of spinal motor neurons in vivo.[Pubmed: 11935257]
    Excitotoxicity, autoimmunity and free radicals have been postulated to play a role in the pathomechanism of amyotrophic lateral sclerosis (ALS), the most frequent motor neuron disease. Altered calcium homeostasis has already been demonstrated in Cu/Zn superoxide dismutase transgenic animals, suggesting a role for free radicals in the pathogenesis of ALS, and in passive transfer experiments, modeling autoimmunity. These findings also suggested that yet-confined pathogenic insults, associated with ALS, could trigger the disruption of calcium homeostasis of motor neurons.
    METHODS AND RESULTS:
    To test the possibility that excitotoxic processes may also be able to increase calcium in motor neurons, we applied the glutamate analogue DL-homocysteic acid to the spinal cord of rats in vivo and analyzed the calcium distribution of the motor neurons over a 24-h survival period by electron microscopy. Initially, an elevated cytoplasmic calcium level, with no morphological sign of degeneration, was noticed. Later, increasing calcium accumulation was seen in different cellular compartments with characteristic features of alteration at different survival times. This calcium accumulation in organelles was paralleled by their progressive degeneration, which culminated in cell death by the end of the observation time. These findings confirm that increased calcium also plays a role in excitotoxic lesion of motor neurons, in line with previous studies documenting the involvement of calcium ions in motor neuronal injury in other models of the disease as well as elevated calcium in biopsy samples from ALS patients.
    CONCLUSIONS:
    We suggest that intracellular calcium might be responsible for the interplay between the different pathogenic processes resulting in a uniform clinicopathological picture of the disease.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 5.4591 mL 27.2956 mL 54.5911 mL 109.1822 mL 136.4778 mL
    5 mM 1.0918 mL 5.4591 mL 10.9182 mL 21.8364 mL 27.2956 mL
    10 mM 0.5459 mL 2.7296 mL 5.4591 mL 10.9182 mL 13.6478 mL
    50 mM 0.1092 mL 0.5459 mL 1.0918 mL 2.1836 mL 2.7296 mL
    100 mM 0.0546 mL 0.273 mL 0.5459 mL 1.0918 mL 1.3648 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    乙胺; Ethylamine CFN00075 75-04-7 C2H7N = 45.08 5mg QQ客服:3257982914
    正庚胺; 1-Heptylamine CFN00077 111-68-2 C7H17N = 115.22 5mg QQ客服:1413575084
    异戊胺; 3-Methyl-1-butylamine CFN00087 107-85-7 C5H13N = 87.16 5mg QQ客服:3257982914
    丙胺; Propylamine CFN00091 107-10-8 C3H9N = 59.11 5mg QQ客服:3257982914
    DL-高磺基丙氨酸; DL-Homocysteic acid CFN90077 504-33-6 C4H9NO5S = 183.18 20mg QQ客服:1457312923
    L-茶氨酸; L-Theanine CFN90429 3081-61-6 C7H14N2O3 = 174.19 20mg QQ客服:3257982914
    L-精氨酸; L-Arginine CFN90550 74-79-3 C6H14N4O2 = 174.20 20mg QQ客服:2056216494
    L-瓜氨酸; L-Citruline CFN90551 372-75-8 C6H13N3O3 = 175.18 20mg QQ客服:215959384
    乙酰胺; Acetamide CFN97025 60-35-5 C2H5NO = 59.1 20mg QQ客服:1413575084

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产